Diligence memo · auto-generated · as of July 2, 2026
Applied Stemcell Inc
Applied Stemcell Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Applied Stemcell Inc operates in Biotechnology, based in MILPITAS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Applied Stemcell Inc has raised $24M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $19M on 2016-05-18.
Most recent recorded round closed around 2016-05-18.
Valuation (modeled)modeled
Provath models Applied Stemcell Inc at approximately $754M (range $38M–$2.9B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.95× the median modeled value of Series B Biotechnology companies in 2016–2018 (101 peers) — value vs value, same stage and era. Within the normal band (95% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 24 months.
Last raise 10.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 70% of Biotechnology peers (4293 compared).
Modeled value ranks above 87% of those peers.
Closest niche peers: Liquid BioScience, Inc., Amphivena Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Tetra Discovery Partners, Inc., ECM Therapeutics, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.